Cerity Partners’s Axcelis ACLS Stock Holding History
Bought
Maintained
Sold
Other funds holding ACLS
VPM
RP
VCM
Cerity Partners's ACLS Position: Q1 2026 in Review
Cerity Partners reduced its Axcelis (ACLS) stake by 35% in Q1 2026, selling an estimated $158K and leaving 3,263 shares worth $304K. The position accounts for ﹤0.01% of the portfolio, ranked #2603.
Cerity Partners first reported a position in ACLS in Q4 2022 and has held it in 13 quarters since. The position peaked at $11.4M in Q2 2024. 377 funds tracked by Wall St. Rank hold ACLS as of Q1 2026.
- Cerity Partners held 3,263 shares of Axcelis worth $304K as of Q1 2026.
- Cerity Partners sold 1,789 Axcelis shares in Q1 2026, an estimated $158K.
- Axcelis made up ﹤0.01% of Cerity Partners's portfolio in Q1 2026, its #2603 holding.
- Cerity Partners first reported a position in Axcelis in Q4 2022 and has held it in 13 quarters since.
- Cerity Partners's Axcelis position peaked at $11.4M in Q2 2024.
- 377 funds tracked by Wall St. Rank held Axcelis as of Q1 2026.
Based on Cerity Partners's 13F filing for Q1 2026, filed 15 May 2026.